632 related articles for article (PubMed ID: 27009953)
21. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.
Yasuda A; Noguchi K; Minoshima M; Kashiwazaki G; Kanda T; Katayama K; Mitsuhashi J; Bando T; Sugiyama H; Sugimoto Y
Cancer Sci; 2011 Dec; 102(12):2221-30. PubMed ID: 21910783
[TBL] [Abstract][Full Text] [Related]
22. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF.
Chau CM; Zhang XY; McMahon SB; Lieberman PM
J Virol; 2006 Jun; 80(12):5723-32. PubMed ID: 16731911
[TBL] [Abstract][Full Text] [Related]
23. The Epstein-Barr Virus Episome Maneuvers between Nuclear Chromatin Compartments during Reactivation.
Moquin SA; Thomas S; Whalen S; Warburton A; Fernandez SG; McBride AA; Pollard KS; Miranda JL
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142137
[TBL] [Abstract][Full Text] [Related]
24. Chromatin profiling of Epstein-Barr virus latency control region.
Day L; Chau CM; Nebozhyn M; Rennekamp AJ; Showe M; Lieberman PM
J Virol; 2007 Jun; 81(12):6389-401. PubMed ID: 17409162
[TBL] [Abstract][Full Text] [Related]
25. Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome.
Lee EK; Kim SY; Noh KW; Joo EH; Zhao B; Kieff E; Kang MS
Antiviral Res; 2014 Apr; 104():73-83. PubMed ID: 24486954
[TBL] [Abstract][Full Text] [Related]
26. Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs.
Schaefer BC; Strominger JL; Speck SH
Mol Cell Biol; 1997 Jan; 17(1):364-77. PubMed ID: 8972217
[TBL] [Abstract][Full Text] [Related]
27. Epstein-Barr Nuclear Antigen 1 modulates replication of oriP-plasmids by impeding replication and transcription fork migration through the family of repeats.
Aiyar A; Aras S; Washington A; Singh G; Luftig RB
Virol J; 2009 Mar; 6():29. PubMed ID: 19265546
[TBL] [Abstract][Full Text] [Related]
28. Maintenance of Epstein-Barr virus (EBV) oriP-based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which can be replaced by high-mobility group-I or histone H1.
Hung SC; Kang MS; Kieff E
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1865-70. PubMed ID: 11172042
[TBL] [Abstract][Full Text] [Related]
29. Protein and sequence requirements for the recruitment of the human origin recognition complex to the latent cycle origin of DNA replication of Epstein-Barr virus oriP.
Julien MD; Polonskaya Z; Hearing J
Virology; 2004 Sep; 326(2):317-28. PubMed ID: 15302216
[TBL] [Abstract][Full Text] [Related]
30. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
[TBL] [Abstract][Full Text] [Related]
31. EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1.
Chen YL; Tsai HL; Peng CW
Biochem Biophys Res Commun; 2012 Jan; 417(3):1093-9. PubMed ID: 22226960
[TBL] [Abstract][Full Text] [Related]
32. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
Puglielli MT; Woisetschlaeger M; Speck SH
J Virol; 1996 Sep; 70(9):5758-68. PubMed ID: 8709191
[TBL] [Abstract][Full Text] [Related]
33. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha.
Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM
Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725
[TBL] [Abstract][Full Text] [Related]
34. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1.
Zhang L; Pagano JS
J Virol; 2000 Feb; 74(3):1061-8. PubMed ID: 10627515
[TBL] [Abstract][Full Text] [Related]
35. CTCF prevents the epigenetic drift of EBV latency promoter Qp.
Tempera I; Wiedmer A; Dheekollu J; Lieberman PM
PLoS Pathog; 2010 Aug; 6(8):e1001048. PubMed ID: 20730088
[TBL] [Abstract][Full Text] [Related]
36. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus.
Wysokenski DA; Yates JL
J Virol; 1989 Jun; 63(6):2657-66. PubMed ID: 2542579
[TBL] [Abstract][Full Text] [Related]
37. Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus.
Fejer G; Koroknai A; Banati F; Györy I; Salamon D; Wolf H; Niller HH; Minarovits J
J Gen Virol; 2008 Jun; 89(Pt 6):1364-1370. PubMed ID: 18474551
[TBL] [Abstract][Full Text] [Related]
38. Role for a region of helically unstable DNA within the Epstein-Barr virus latent cycle origin of DNA replication oriP in origin function.
Polonskaya Z; Benham CJ; Hearing J
Virology; 2004 Oct; 328(2):282-91. PubMed ID: 15464848
[TBL] [Abstract][Full Text] [Related]
39. EBNA1 efficiently assembles on chromatin containing the Epstein-Barr virus latent origin of replication.
Avolio-Hunter TM; Frappier L
Virology; 2003 Oct; 315(2):398-408. PubMed ID: 14585343
[TBL] [Abstract][Full Text] [Related]
40. GAP31 from an ancient medicinal plant exhibits anti-viral activity through targeting to Epstein-Barr virus nuclear antigen 1.
Shen CL; Huang WH; Hsu HJ; Yang JH; Peng CW
Antiviral Res; 2019 Apr; 164():123-130. PubMed ID: 30817940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
